Literature DB >> 12427652

Arterial stiffness and endothelial function in patients with beta-thalassemia major.

Y F Cheung1, Godfrey C F Chan, S Y Ha.   

Abstract

BACKGROUND: Increased iron store has been linked to risk of cardiovascular disease. Structural alterations of arteries in beta-thalassemia major patients and in vitro functional disturbance of vascular endothelial cells by thalassemic serum have been described. We sought to determine whether arterial stiffness and endothelial function are altered in vivo. METHODS AND
RESULTS: Thirty thalassemia patients (16 male) aged 22.2+/-7.4 years were recruited. Left ventricular (LV) mass and function were assessed echocardiographically. Carotid and brachioradial artery stiffness was assessed by stiffness index and pulse-wave velocity (PWV), respectively. Brachial artery endothelial function was assessed by vascular response to reactive hyperemia (flow-mediated dilation [FMD]) and sublingual glyceryl trinitrate. These indexes were compared with those of 30 age- and sex-matched controls. None of the patients had LV systolic or diastolic dysfunction. When compared with controls, patients had greater absolute (113.8+/-38.0 versus 109.0+/- 32.6 g, P=0.04) and indexed (82.4+/-17.5 versus 66.7+/-12.7 g/m(2), P<0.001) LV mass, carotid artery stiffness index (8.1+/-3.5 versus 5.5+/-1.6, P<0.001), and brachioradial PWV (8.9+/-2.4 versus 7.9+/-1.7 m/s, P= 0.03). Their FMD was impaired (3.5+/-3.3% versus 8.8+/-3.9%, P<0.001), whereas glyceryl trinitrate- mediated dilation was preserved (17.9+/-7.6% versus 16.3+/-6.1%, P=0.40). Both stiffness index and PWV correlated inversely with magnitude of FMD (r=-0.40, P=0.03; r=-0.41, P=0.03) and positively with indexed LV mass (r=0.50, P=0.005; r=0.40, P=0.027). Nonetheless, no significant correlation existed between ferritin level and carotid stiffness, PWV, or FMD.
CONCLUSIONS: Increased arterial stiffness, endothelial dysfunction, and LV hypertrophy occur in patients with beta-thalassemia major, which may result in reduction of mechanical efficiency of the heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427652     DOI: 10.1161/01.cir.0000037225.92759.a7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  38 in total

Review 1.  The latest generation of beta-blockers: new pharmacologic properties.

Authors:  Michala E Pedersen; John R Cockcroft
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

2.  Abnormalities in aortic properties: a potential link between left ventricular diastolic function and ventricular-aortic coupling in sickle cell disease.

Authors:  Emilie Bollache; Nadjia Kachenoura; Roberto M Lang; Ankit A Desai; Victor Mor-Avi; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-23       Impact factor: 2.357

3.  Blockade of angiotensin AT1 receptors prevents arterial remodelling and stiffening in iron-overloaded rats.

Authors:  Helbert Gabriel Fidelis; Jandinay Gonzaga Alexandre Mageski; Susana Curry Evangelista Goes; Tatiani Botelho; Vinicius Bermond Marques; Renata Andrade Ávila; Leonardo Dos Santos
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

4.  Iron, inflammation and atherosclerosis risk in men vs. perimenopausal women.

Authors:  Subha V Raman; Travis P Sharkey-Toppen; Tam Tran; Jim X Liu; Beth McCarthy; Xin He; Suzanne Smart; Martha Gulati; Randell Wexler; Orlando P Simonetti; Rebecca D Jackson
Journal:  Atherosclerosis       Date:  2015-03-20       Impact factor: 5.162

5.  Altered vascular function, arterial stiffness, and antioxidant gene responses in pediatric thalassemia patients.

Authors:  Pantipa Detchaporn; Upa Kukongviriyapan; Auemduan Prawan; Arunee Jetsrisuparb; Stephen E Greenwald; Veerapol Kukongviriyapan
Journal:  Pediatr Cardiol       Date:  2012-02-14       Impact factor: 1.655

6.  Depleted nitric oxide and prostaglandin E2 levels are correlated with endothelial dysfunction in β-thalassemia/HbE patients.

Authors:  Sudarat Satitthummanid; Noppacharn Uaprasert; Smonporn Boonyaratavej Songmuang; Ponlapat Rojnuckarin; Piyaratana Tosukhowong; Pranee Sutcharitchan; Suphot Srimahachota
Journal:  Int J Hematol       Date:  2017-05-04       Impact factor: 2.490

7.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

8.  Pulmonary hypertension in well-transfused thalassemia major patients.

Authors:  Antonella Meloni; Jon Detterich; Alessia Pepe; Paul Harmatz; Tom D Coates; John C Wood
Journal:  Blood Cells Mol Dis       Date:  2014-11-24       Impact factor: 3.039

9.  Arterial stiffness in the young: assessment, determinants, and implications.

Authors:  Yiu-Fai Cheung
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

10.  Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia.

Authors:  Veerapol Kukongviriyapan; Nuntiya Somparn; Laddawan Senggunprai; Auemduan Prawan; Upa Kukongviriyapan; Arunee Jetsrisuparb
Journal:  Pediatr Cardiol       Date:  2007-09-22       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.